Total Payments
$257,150
2024 Payments
$38,644
Companies
39
Transactions
238
Medicare Patients
526
Medicare Billing
$103,122
Payment Breakdown by Category
Consulting$191,951 (74.6%)
Other$32,648 (12.7%)
Travel$15,729 (6.1%)
Research$9,671 (3.8%)
Food & Beverage$7,042 (2.7%)
Education$108.99 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $191,951 | 72 | 74.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $24,836 | 10 | 9.7% |
| Travel and Lodging | $15,729 | 45 | 6.1% |
| Unspecified | $9,671 | 7 | 3.8% |
| Food and Beverage | $7,042 | 99 | 2.7% |
| Honoraria | $6,500 | 2 | 2.5% |
| Compensation for serving as faculty or as a speaker for a medical education program | $1,311 | 1 | 0.5% |
| Education | $108.99 | 2 | 0.0% |
Payments by Type
General
$247,479
231 transactions
Research
$9,671
7 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $49,957 | 33 | $0 (2024) |
| AstraZeneca UK Limited | $39,135 | 9 | $0 (2024) |
| SERVIER PHARMACEUTICALS LLC | $20,691 | 9 | $0 (2022) |
| Merck Sharp & Dohme LLC | $20,391 | 28 | $0 (2023) |
| Incyte Corporation | $17,332 | 21 | $0 (2023) |
| Agios Pharmaceuticals, Inc. | $13,699 | 9 | $0 (2020) |
| Jazz Pharmaceuticals Inc. | $11,455 | 11 | $0 (2023) |
| Exelixis Inc. | $11,386 | 17 | $0 (2022) |
| Taiho Oncology, Inc. | $9,285 | 6 | $0 (2022) |
| Celgene Corporation | $8,077 | 8 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $38,644 | 32 | AstraZeneca Pharmaceuticals LP ($16,307) |
| 2023 | $44,061 | 48 | AstraZeneca Pharmaceuticals LP ($22,861) |
| 2022 | $44,463 | 17 | AstraZeneca UK Limited ($18,495) |
| 2021 | $49,102 | 27 | Servier Pharmaceuticals LLC ($13,211) |
| 2020 | $21,687 | 19 | AstraZeneca UK Limited ($4,453) |
| 2019 | $31,588 | 44 | Merck Sharp & Dohme Corporation ($14,641) |
| 2018 | $18,951 | 27 | Seattle Genetics, Inc. ($7,645) |
| 2017 | $8,654 | 24 | Halozyme Inc ($6,676) |
All Payment Transactions
238 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $7,535.00 | General |
| 11/09/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,480.00 | General |
| Category: Oncology | ||||||
| 11/09/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 10 GBq (Device) | Food and Beverage | In-kind items and services | $396.86 | General |
| Category: TheraSphere_PI | ||||||
| 11/08/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 10 GBq (Device) | Food and Beverage | In-kind items and services | $601.80 | General |
| Category: TheraSphere_PI | ||||||
| 11/07/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 10 GBq (Device) | Travel and Lodging | In-kind items and services | $369.08 | General |
| Category: TheraSphere_PI | ||||||
| 11/07/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 10 GBq (Device) | Travel and Lodging | In-kind items and services | $300.55 | General |
| Category: TheraSphere_PI | ||||||
| 11/07/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 10 GBq (Device) | Food and Beverage | In-kind items and services | $191.95 | General |
| Category: TheraSphere_PI | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $2,055.00 | General |
| 09/26/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) (Device) | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| Category: TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)_PI | ||||||
| 09/26/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) (Device) | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| Category: TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)_PI | ||||||
| 09/14/2024 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $26.66 | General |
| 09/13/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $100.95 | General |
| 08/14/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Education | In-kind items and services | $9.00 | General |
| Category: Oncology | ||||||
| 07/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $81.96 | General |
| 07/25/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) (Device) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)_PI | ||||||
| 06/29/2024 | PFIZER INC. | BRAFTOVI (Drug), TUKYSA | Food and Beverage | In-kind items and services | $57.98 | General |
| Category: ONCOLOGY | ||||||
| 06/21/2024 | Galvanize Therapeutics, Inc | ALIYA SYSTEM (Device) | Food and Beverage | In-kind items and services | $122.32 | General |
| Category: PULSED ELECTRIC FIELD | ||||||
| 06/02/2024 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $46.49 | General |
| 05/31/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $75.00 | General |
| 05/31/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $25.00 | General |
| 04/18/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $2,055.00 | General |
| Category: Oncology | ||||||
| 03/01/2024 | Regeneron Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $5,286.00 | General |
| 03/01/2024 | Regeneron Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $881.00 | General |
| 02/29/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $1,370.00 | General |
| Category: Oncology | ||||||
| 02/06/2024 | AstraZeneca UK Limited | SAPHNELO (Biological) | Consulting Fee | Cash or cash equivalent | $8,994.75 | General |
| Category: Inflammation and Autoimmunity | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| AX-CL-OTHER-PI-003908 - A phase II study of gemcitabine, cisplatin and Abraxane in advanced biliary cancers | Celgene Corporation | $6,699 | 1 |
| STUDY OF AG-120 IN PREVIOUSLY TREATED ADVANCED CHOLANGIOCARCINOMA WITH IDH1 MUTATIONS (CLARIDHY) (CLARIDHY) | SERVIER AFFAIRES MEDICALES | $1,158 | 2 |
| NCI-2015-00578 | Celgene Corporation | $1,071 | 1 |
| RESEARCH RELATED PUBLICATION SUPPORT | NOVARTIS PHARMACEUTICALS CORPORATION | $673.21 | 1 |
| TAS 120 | Taiho Oncology, Inc. | $70.01 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 111 | 206 | $45,745 | $21,523 |
| 2022 | 3 | 122 | 241 | $55,730 | $26,853 |
| 2021 | 3 | 144 | 289 | $69,103 | $33,114 |
| 2020 | 5 | 149 | 270 | $58,787 | $21,631 |
Total Patients
526
Total Services
1,006
Medicare Billing
$103,122
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 72 | 162 | $35,919 | $17,179 | 47.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $5,957 | $2,289 | 38.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 23 | 28 | $3,869 | $2,055 | 53.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 70 | 183 | $40,794 | $20,826 | 51.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 30 | 30 | $11,067 | $3,925 | 35.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 22 | 28 | $3,869 | $2,102 | 54.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 82 | 224 | $50,674 | $25,573 | 50.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 49 | 49 | $17,885 | $7,154 | 40.0% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 13 | 16 | $544.00 | $387.60 | 71.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 68 | 180 | $41,067 | $15,070 | 36.7% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 37 | 37 | $13,739 | $4,928 | 35.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 13 | 13 | $2,093 | $736.48 | 35.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 14 | 16 | $1,072 | $656.72 | 61.3% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 17 | 24 | $816.00 | $239.77 | 29.4% |
About Dr. Rachna Shroff, MD
Dr. Rachna Shroff, MD is a Hematology & Oncology healthcare provider based in Tucson, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/13/2007. The National Provider Identifier (NPI) number assigned to this provider is 1942425350.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rachna Shroff, MD has received a total of $257,150 in payments from pharmaceutical and medical device companies, with $38,644 received in 2024. These payments were reported across 238 transactions from 39 companies. The most common payment nature is "Consulting Fee" ($191,951).
As a Medicare-enrolled provider, Shroff has provided services to 526 Medicare beneficiaries, totaling 1,006 services with total Medicare billing of $103,122. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Tucson, AZ
- Active Since 04/13/2007
- Last Updated 08/30/2024
- Taxonomy Code 207RH0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1942425350
Products in Payments
- IMFINZI (Biological) $50,991
- TIBSOVO (Drug) $34,390
- ZANIDATAMAB $11,455
- SAPHNELO (Biological) $8,995
- Abraxane (Drug) $7,884
- Cabometyx (Drug) $7,136
- LENVIMA (Drug) $4,673
- Onivyde (Drug) $3,480
- LYNPARZA (Drug) $3,425
- INQOVI (Drug) $3,300
- Lonsurf (Drug) $2,640
- TECENTRIQ (Biological) $2,200
- CABOMETYX (Drug) $2,085
- TheraSphere Y90 Glass Microspheres 10 GBq (Device) $1,860
- Lucitanib (Drug) $1,554
- TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) (Device) $1,200
- Tibsovo (Drug) $1,158
- TRUSELTIQ (Drug) $1,068
- Vitrakvi (Drug) $900.00
- BGJ398 (Drug) $673.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Tucson
Dr. Christopher Chen, Md, Mba, MD, MBA
Hematology & Oncology — Payments: $312,281
Hematology & Oncology $312,281
Alison Stopeck, Md, MD
Hematology & Oncology — Payments: $240,782
Hematology & Oncology $240,782
Michael Boxer, M.d, M.D
Hematology & Oncology — Payments: $86,711
Hematology & Oncology $86,711
Dr. Rachel Swart, M.d.,Ph.d, M.D.,PH.D
Hematology & Oncology — Payments: $69,563
Hematology & Oncology $69,563
Sudhir Manda, Md, MD
Hematology & Oncology — Payments: $50,979
Hematology & Oncology $50,979
Basel Shoua, M.d, M.D
Hematology & Oncology — Payments: $45,611
Hematology & Oncology $45,611